SARS-CoV-2 omicron variant: Could it be another threat?

JOURNAL OF MEDICAL VIROLOGY

WILEY

1. National Vaccine Institute, Thailand
2. Baiya Phytopharm Co., Ltd., Thailand
3. Second Century Fund(C2F), Chulalongkorn University